ArticleCancer research2015

CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.

Hyun-Bae Jie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.